← Open Payments lookup

AUDREY FORKA: Open Payments

NPI 1780087213 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$923 in 41 payments from 15 companies in 2025. Trend: 2023 $716 · 2024 $1,175 · 2025 $923

Food & beverage: $923
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$198
Supernus Pharmaceuticals, Inc.5$100
ABBVIE INC.5$91
Otsuka America Pharmaceutical, Inc.4$89
Janssen Pharmaceuticals, Inc3$87
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Alkermes, Inc.3$55
E.R. Squibb & Sons, L.L.C.2$53
Axsome Therapeutics, Inc.2$39
Collegium Pharmaceutical, Inc.2$37

Products named: INGREZZA, Qelbree, INVEGA SUSTENNA, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, COBENFY, Auvelity.

Industry payments across MD — which companies pay providers there.